Bayer Aktiengesellschaft (BAYRY)
OTCMKTS
· Delayed Price · Currency is USD
6.44
-0.33 (-4.87%)
Nov 6, 2024, 2:00 PM EST
Bayer Aktiengesellschaft Employees
Bayer Aktiengesellschaft had 96,931 employees as of December 31, 2023. The number of employees decreased by 991 or -1.01% compared to the previous year.
Employees
96,931
Change (1Y)
-991
Growth (1Y)
-1.01%
Revenue / Employee
$522,746
Profits / Employee
-$14,047
Market Cap
25.25B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 96,931 | -991 | -1.01% |
Dec 31, 2022 | 97,922 | 1,972 | 2.06% |
Dec 31, 2021 | 95,950 | -5 | -0.01% |
Dec 31, 2020 | 95,955 | -2,782 | -2.82% |
Dec 31, 2019 | 98,737 | -12,278 | -11.06% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Related Stocks
Company Name | Employees |
---|---|
Sandoz Group AG | 22,633 |
Telix Pharmaceuticals Limited | 234 |
Elekta AB (publ) | 4,718 |
Ryman Healthcare Limited | 7,700 |
Verano Holdings Corp. | 3,900 |
Vireo Growth Inc. | 490 |
Medexus Pharmaceuticals Inc. | 82 |
Bayer Aktiengesellschaft News
- 7 days ago - Bayer and Liveo Research Launch First-of-its-Kind Blister Packaging with Improved Environmental Footprint - Business Wire
- 22 days ago - Bayer submits EU marketing application for menopause relief drug - Reuters
- 23 days ago - Bayer Seeks European Approval For Third Indication For Cancer Drug Darolutamide - Benzinga
- 23 days ago - Bayer applies for third indication of Nubeqa in EU - Reuters
- 23 days ago - Orion's collaboration partner Bayer submits application for third indication of darolutamide in the EU - GlobeNewsWire
- 26 days ago - Bayer must pay $78 mln in latest Roundup cancer trial, jury finds - Reuters
- 27 days ago - Bayer shares fall 7% as US court reconsiders Monsanto PCB exposure case - Invezz
- 4 weeks ago - Bayer plunges after U.S. court accepts review of Washington PCB case - Seeking Alpha